Buprenorphine Quick Start Guide - SAMHSA
services if office-based treatment with. buprenorphine or naltrexone is not effective, or the clinician does not have the resources to meet a particular patient’s needs. Providers can find programs in their areas or throughout the United States by using SAMHSA’s Behavioral Health Treatment Services Locator at www.findtreatment.samhsa.gov.
Download Buprenorphine Quick Start Guide - SAMHSA
Information
Domain:
Source:
Link to this page:
Documents from same domain
State Mental Health Authorities Directory
www.samhsa.govIowa Department of Human Services, Division of Mental Health and Disability Services . 1305 E. Walnut Des Moines, IA 50319 Phone:
SAMHSA Disaster Technical Assistance Center …
www.samhsa.govDisaster Behavioral Health Interventions Inventory ... Cognitive Behavioral Therapy for Acute Stress Disorder ... (CBI) ...
National Mental Health Services Survey (N-MHSS): …
www.samhsa.govPublication No. (SMA) 17-5049. ... 2016 ... National Mental Health Services Survey (N-MHSS), 2016. MHSS. Data . treatment facilities.
Key Substance Use and Mental Health Indicators in …
www.samhsa.govHowever, this publication may not be reproduced or distributed for a fee without the specific, ... adolescents aged 12 to 17 was lower in 2016 than in most
Results from the 2013 National Survey on Drug Use …
www.samhsa.govResults from the 2013 National Survey on Drug Use and Health: Summary of National Findings U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration
FREQUENTLY ASKED QUESTIONS - SAMHSA
www.samhsa.govFrequently Asked Questions Applying the Substance Abuse Confidentiality Regulations to Health Information Exchange (HIE)1 Prepared by the Legal Action Center for the
Single State Agency (SSA) Directory - samhsa.gov
www.samhsa.govNEBRASKA . Sheri Dawson, R.N. Division of Behavioral Health . Nebraska Department of Health and Human Services . P.O. Box 95026 . Nebraska State Office Building
Single State Agency (SSA) Directory - SAMHSA
www.samhsa.govDirectory of Single State Agencies (SSA) for Substance Abuse Services Center for Substance Abuse Treatment Division of State and Community Assistance
National Prevention Week 2018 - samhsa.gov
www.samhsa.govNational Prevention Week 2018 WHAT IS NATIONAL PREVENTION WEEK? ... the prevention of substance use and promotion of mental health. The observance brings individuals, organizations, coalitions, states, and communities together through local events to raise awareness about the ... importance of preventing substance use and mental disorders. WHEN ...
Successful Strategies for Recruiting, Training, and ...
www.samhsa.govSuccessful Strategies for Recruiting, Training, and Utilizing Volunteers is a guidance handbook designed for community groups and faith-based organizations seeking to maximize the skills of their volunteers, expand their services to the community, and enhance their effectiveness.
Related documents
Federal Guidelines for Opioid Treatment Programs
store.samhsa.govOffice-based opioid treatment (OBOT). • Approval of ER injectable naltrexone for opioid dependence. Between 2012 and 2014, SAMHSA sought the input of panel members, other federal and state agency staff, and members of the public for the third edition of the guidelines, entitled Federal Guidelines for Opioid Treatment Programs (Guidelines).
SAMHSA Opioid Overdose Toolkit
store.samhsa.govprovide care in office-based settings with buprenorphine and naltrexone. Information on treatment services available in or near your community can be obtained from your state health department, your state alcohol and drug agency, or the SAMHSA Behavioral Health Treatment Services Locator at . https://www.findtreatment.samhsa.gov.
The ASAM National Practice Guideline Supplement
www.asam.orgment of addiction have specific efficacy based on their own molecular structure and the particular neurotransmitters affected by that medication. Medications developed for the treatment of addiction involving opioid use may have benefits in the treatment of addiction involving an individual’s use of other substances.
MLN8296732 Opioid Treatment Programs (OTPs) Medicare ...
www.cms.govBuprenorphine implants (insertion, removal, and insertion/removal) (G2070, G2071, and G2072) Extended-release, injectable naltrexone (G2073) Non-drug bundle (G2074) • You didn’t administer medication during an episode of care. • Example: In the case of a patient getting injectable buprenorphine, OTPs bill HCPCS code G2069
Drug Addiction and Federal Disability Rights Laws Fact Sheet
www.hhs.govfederal disability rights protections is a fact- specific inquiry based on the criteria described above. However, persons receiving MAT cannot be, by virtue of that fact, excluded from protection under federal disability rights laws. Because MAT related medications are prescribed and are taken under the supervision of a